Ansell Healthcare takes LifeStyles thin condoms thinner with Zero launch
ISELIN, N.J. — Ansell Healthcare on Wednesday announced the launch of Zero and Zero Larger. Zero is the thinnest latex condom now offered in America, 45% thinner than Ansell’s standard latex design, and Zero Larger is now the thinnest large condom in the market in the United States, the company stated.
According to consumer focus groups, condom users are consistently searching for more sensitive and better-fitting designs, and are willing to try different brands and styles to discover the condoms that best suit their needs.
"At Ansell, we are constantly striving to bring sexually active consumers the most advanced products on the market, developed by conducting rigorous consumer research," stated Carol Carrozza, VP sales and marketing North America for Ansell Healthcare. "Responding to consumer requests, we are thrilled to introduce our thinnest condoms yet, Zero and Zero Larger, offering users what they desire most: greater sensitivity, extended pleasure and quite frankly, better sex."
The release of Zero also features an innovation in packaging design for the condom category. The unique packaging features a contemporary, matchbox-like design that slides open for easy access. The product name, metallic Zero logo, solid white background and packaging fonts all demonstrate a modern, sleek and sexy update to typical condom packaging — a new, innovative look for the new, advanced Zero series.
Successful Australian VMS marketer to launch in the U.S. market January 2013
VICTORIA, Australia — Sales of Swisse Ultivite multivitamins in the Australian and Asian markets have been a big driver behind overall sales, according to a Nielsen report cited by the company.
Across both Australia and Asia, VMS sales were up 16% to $197 million for the year ended June 2012. Leading the charge was Suisse Ultivite, which grew by more than 40% "thanks to a high ad spend and launches that boost the profile of the whole range,” Nielsen said.
“Swisse is about educating all people on their health, and they understand the role of multivitamins, particularly in their busy lives where diets are not supplying all they need,” stated Radek Sali, Swisse CEO. “The Swisse marketing position is evolving as the market matures, and we establish ourselves on the global VMS platform.”
Swisse was also identified as being a prospective driver of growth in the herbal and natural supplements category where fish oils were relatively flat but krill oil developed as a new interest area because of its greater potency. “Swisse has over 20 brand ambassadors and was Australian broadcast sponsor of the London 2012 Olympics and is associated with several other sporting events," Sali said. "In May 2012, Swisse enlisted actress and singer Delta Goodrem to advertise the brand on TV, and in June 2012, the marketer signed a sponsorship deal to be the official vitamin of the Qantas Wallabies Rugby Union team."
Meanwhile, the company has hired actress Nicole Kidman as global brand ambassador ahead of the rollout of Swisse in the United States in January 2013.
Swisse has also launched a body and skin care portfolio and the Swisse Active range of premium whey powder and energy bars, the company noted.
Study: Vitamin D supplementation helps people with lupus erythematosus
LONDON — Vitamin D supplementation could be considered an immunomodulatory agent for systemic lupus erythematosus, an autoimmune disease characterized not only by skin, joint, neurological and renal symptoms, but also by inflammation of tissue linings in the body, according to a new clinical study published Tuesday in BioMedCentral’s open access journal Arthritis Research and Therapy.
An immunomodulatory agent has an effect on the immune system.
In a prospective clinical trial, Nathalie Costedoat-Chalumeau and colleagues set out to evaluate the safety and immunological effects of vitamin D supplementation in 20 SLE patients with low vitamin D levels. They observed these patients over six months and found that vitamin D was not only well-tolerated but, more importantly, there also were no SLE flare-ups during the follow-up period. The authors found that no modification of existing immunosuppressant drugs was needed, nor any new drugs initiated.
Costedoat-Chalumeau stated that the findings confirm that vitamin D may also play other roles in the immune system.